Metabotropic Glutamate Receptor 5 Negative Modulation in Phase I Clinical Trial: Potential Impact of Circadian Rhythm on the Neuropsychiatric Adverse Reactions—Do Hallucinations Matter?
Table 3
Onset and end of (pseudo) hallucinations reported from/observed in 11 subjects during the course of the clinical trial.